SANUWAVE Health, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From SANUWAVE Health, Inc.
Also, deals between Boehringer Ingelheim/Oxford BioTherapeutics, Bausch/Eyenovia, Ligand/HitGen, Moderna/Merck & Co., Vincera/Bayer, Genentech/Kineta, Selecta/IGAN, RedHill/AstraZeneca, Urovant/Sunovion, Biogen/Scribe, BridgeBio/Eidos, Elevar/Taiba
New OTC dermatology products on the German market, including line extensions from Englehard, Medice and Stada and a 0.5% hydrocortisone cream from Sandoz.
Two prescription-to-OTC switch applications rejected by Germany’s Expert Committee for Prescription: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use.
Germany's Expert Committee for Prescription will meet on 22 January to consider two prescription-to-OTC switch applications: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use.
- Medical Devices
- Other Names / Subsidiaries
- SANUWAVE Inc